Tag Prevención

23 Apr

Communication, a crucial tool for improving the quality of life of osteoarthritis patients

OA is a degenerative disease que afecta al cartílago, hueso subcondral y tejidos blandos de la articulación. Según publicaciones recientes, se calcula que ya la sufren casi 600 millones de personas en todo el mundo y las previsiones apuntan a que estos números aumentaran de manera acelerada con el aumento de la esperanza de vida. […]

READ MORE

18 Apr

Transforming lives

“Transforming lives: the importance of your support to OAFI”. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by wear and tear of the articular cartilage, resulting in pain, stiffness and loss of mobility. Osteoarthritis is a disease that can have a significant impact on the quality of life […]

READ MORE

15 Apr

Health dimension of osteoarthritis

CHALLENGES AND MEASURES TO IMPROVE QUALITY OF CARE In this new meeting, we will analyze the health situation in relation to the progressive increase of patients with osteoarthritis in Spain and its consequences, especially with regard to primary care, and we will propose measures that will enable an effective and sustainable present and future solution, […]

READ MORE

18 Jan

OAFI and AECOSAR, sign agreement with ACES

The signed agreement will enable joint actions for the improvement of osteoarthritis patients in health institutions. On Wednesday 17 January, OAFI and AECOSAR signed an agreement with ACES (Catalan Association of Health Entities), a non-profit business association whose mission is to defend, promote and develop care in private health centres. The aim is to cover […]

READ MORE

20 Nov

Prevention and early diagnosis of Osteoarthritis

Article courtesy of Dr. Francisco Castro-Domínguez, Head of Section, Rheumatology Department, Centro Médico Teknon, Barcelona. Coordinator, SER Working Group on Arthrosis, ARTROSER, Spanish Society of Rheumatology. Introduction In Spain, osteoarthritis affects around 7 million people and according to the EPISER 2016 study, the prevalence of osteoarthritis in one or more locations in the population over […]

READ MORE

4 Oct

Banco Farmacéutico, OAFI and AECOSAR win the First Prize for Patients’ Associations in the VI Edition of the Treatment Adherence Observatory Award

OAFI, AECOSAR and Banco Farmacéutico, have been distinguished with the first prize for Patient Associations at the OAT awards for their work in improving access to effective treatments for patients at risk of pharmaceutical poverty. This recognition highlights their commitment to health and their determination to continue changing lives through safe treatment tailored to patients’ […]

READ MORE

12 Sep

CHAPTER 1: Bone Health and Vitamin D. What is it and why is it so important?

Vitamina D y Salud Articular

READ MORE

6 Sep

Osteoarthritis and osteoporosis increase the risk of “silent falls” in elderly people.

OAFI y Indeelift

READ MORE

13 Jul

Osteoarthritis and cardiovascular diseases: a close relationship

Osteoarthritis and cardiovascular risk: What do we need to know? Osteoarthritis: Key concepts Osteoarthritis (OA) is a chronic disease that affects the cartilage, the subchondral bone, the synovial membrane and the soft tissues of the joint. Some of the symptoms are pain, loss of mobility, muscle atrophy… which are combined with the psychological wear and […]

READ MORE

13 Jul

SEMERGEN and OAFI united once again

SEMERGEN joins the OAFI Foundation in the development of the “OAFI With You” project, aimed at assisting religious patients with joint health problems. The Spanish Society of Primary Care Physicians (SEMERGEN) and the Osteoarthritis Foundation International (OAFI) have signed a collaboration agreement to promote the development of the “OAFI With You” project, focused on providing […]

READ MORE